Frontier Medicines Reveals Preclinical Data for FMC-220 at AACR 2025
28 Apr 2025 //
GLOBENEWSWIRE
Frontier Medicines to Join Two March Investor Conferences
27 Feb 2025 //
GLOBENEWSWIRE
Frontier Medicines Introduces FMC-220 as Covalent p53 Activator
09 Jan 2025 //
GLOBENEWSWIRE
Frontier Medicines to Present at 43rd Annual J.P. Morgan Conference
08 Jan 2025 //
GLOBENEWSWIRE
Frontier Medicines Gets Milestone Payment In AbbVie Partnership
23 Jul 2024 //
GLOBENEWSWIRE
Frontier Medicines Appoints Gerardo Ubaghs as Chief Financial Officer
25 Jun 2024 //
GLOBENEWSWIRE
Frontier Medicines Presents FMC-376 Data at AACR
09 Apr 2024 //
GLOBENEWSWIRE
Frontier Medicines Appoints Setareh “SiSi” Pouraghabagher to Board of Directors
08 Nov 2022 //
GLOBENEWSWIRE
Frontier Announces the Appointment of Mark Dizon as General Counsel
25 Aug 2022 //
GLOBENEWSWIRE
An RA-backed startup `ATACs` a novel challenge
18 Nov 2021 //
ENDPTS
				
				 
				  			
 Market Place
 Sourcing Support